表紙
市場調查報告書

注射式藥物輸送設備:醫療設備的開發平台評估

Injectable Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020

出版商 GlobalData 商品編碼 851180
出版日期 內容資訊 英文 386 Pages
訂單完成後即時交付
價格
注射式藥物輸送設備:醫療設備的開發平台評估 Injectable Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020
出版日期: 2020年10月31日內容資訊: 英文 386 Pages
簡介

本報告提供全球注射式藥物遞送設備市場上的主要開發中產品 (醫療設備) 及其臨床實驗的進展調查,再彙整產品的功能·特性比較分析 (臨床實驗的各進展階段) ,以及主要企業簡介及代表性產品,近來的市場動靜 (業績報告·資本交易趨勢等) 等資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 注射式藥物輸送設備概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各領域
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 注射式藥物輸送設備的企業:各臨床實驗階段的開發中產品
  • 注射式藥物輸送設備:各臨床實驗階段的開發中產品

第5章 注射式藥物輸送設備市場:企業·產品概要

  • AdrenaCard, Inc.
  • Allergan Plc
  • Alsensa ApS
  • Antares Pharma Inc
  • Aquavit Pharmaceuticals Inc
  • Artemes Technologies, Inc.
  • Ascendis Pharma A/S
  • Ascil Proyectos SL
  • ASIS Corp
  • AzureBio SL
  • BCWorld Pharm Co Ltd
  • Becton Dickinson and Co
  • Bespak Europe Ltd
  • BioCorRx Inc
  • BioMarin Pharmaceutical Inc
  • BioRestorative Therapies Inc
  • Bioxis Pharmaceuticals
  • Brigham and Women's Hospital
  • Burke Pharmaceuticals LLC
  • Callisyn Biomedical Inc
  • Cambridge Consultants Ltd
  • Camurus AB
  • Case Western Reserve University
  • Catalent Inc
  • Cincinnati Children's Hospital Medical Center
  • Clearside BioMedical Inc
  • DALI Medical Devices Ltd.
  • DelSite, Inc. (Inactive)
  • Drexel University
  • Elcam Medical
  • EmboMedics Inc
  • Emergent BioSolutions Inc
  • EP Global Communications Inc (Inactive)
  • EP Technologies LLC
  • Eveon SAS
  • EyePoint Pharmaceuticals Inc
  • FHC Inc
  • GeneSYS-ID Inc
  • Ghent University
  • Globe Medical Tech Inc (Inactive)
  • Inovio Pharmaceuticals Inc
  • InVivo Therapeutics Corp
  • Ipsen SA
  • JCR Pharmaceuticals Co Ltd
  • Lohmann Therapie-Systeme AG
  • LyoGo
  • Mallinckrodt Plc
  • Mertiva AB
  • Midas Pharma GmbH
  • Milestone Scientific Inc
  • NanoPass Technologies Ltd
  • Novosanis NV
  • Osteo Pharma BV
  • Oval Medical Technologies Ltd
  • Particle Therapeutics Ltd
  • Pfizer Inc
  • Portal Instruments Inc
  • Queen Elizabeth Hospital
  • QuiO Technologies LLC
  • RepliCel Life Sciences Inc
  • Rescitech Vision Pvt Ltd
  • RetinaPharma Technologies Inc
  • Revance Therapeutics Inc
  • Roche Diagnostics International Ltd
  • 札幌醫科大學醫學系
  • 武田藥品工業
  • TCB medical devices
  • Terumo Corporation
  • Teva Pharmaceutical Industries Ltd
  • TheraKine Inc (Inactive)
  • Twin Star Medical Inc
  • Unilife Corporation
  • University of Calgary
  • University of California San Diego
  • University of California San Francisco
  • University of Delaware
  • University of Dundee
  • University of Florida
  • University of Saskatchewan
  • University of Texas at Austin
  • Vanderbilt University
  • West Pharmaceutical Services Inc
  • Windgap Medical Inc
  • XERIS Pharmaceuticals Inc
  • Ypsomed Holding AG

第6章 注射式藥物輸送設備市場:目前的趨勢

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME1017EPD

GlobalData's Medical Devices sector report, "Injectable Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Injectable Drug Delivery Devicess pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Injectable Drug Delivery Devices are defined as administration of a drug into patient's blood through a delivery device.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Injectable Drug Delivery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Injectable Drug Delivery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Injectable Drug Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Injectable Drug Delivery Overview

3 Products under Development

  • 3.1 Injectable Drug Delivery - Pipeline Products by Stage of Development
  • 3.2 Injectable Drug Delivery - Pipeline Products by Segment
  • 3.3 Injectable Drug Delivery - Pipeline Products by Territory
  • 3.4 Injectable Drug Delivery - Pipeline Products by Regulatory Path
  • 3.5 Injectable Drug Delivery - Pipeline Products by Estimated Approval Date
  • 3.6 Injectable Drug Delivery - Ongoing Clinical Trials

4 Injectable Drug Delivery - Pipeline Products under Development by Companies

  • 4.1 Injectable Drug Delivery Companies - Pipeline Products by Stage of Development
  • 4.2 Injectable Drug Delivery - Pipeline Products by Stage of Development

5 Injectable Drug Delivery Companies and Product Overview

6 Injectable Drug Delivery- Recent Developments 2137 Appendix

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us

List of Tables

List of Tables

  • Table 1: Injectable Drug Delivery - Pipeline Products by Stage of Development
  • Table 2: Injectable Drug Delivery - Pipeline Products by Segment
  • Table 3: Injectable Drug Delivery - Pipeline Products by Territory
  • Table 4: Injectable Drug Deliv

List of Figures

List of Figures

  • Figure 1: Injectable Drug Delivery - Pipeline Products by Stage of Development
  • Figure 2: Injectable Drug Delivery - Pipeline Products by Segment
  • Figure 3: Injectable Drug Delivery - Pipeline Products by Territory
  • Figure 4: Injectable Drug Delivery - Pipeline Products by Regulatory Path
  • Figure 5: Injectable Drug Delivery - Pipeline Products by Estimated Approval Date
  • Figure 6: Injectable Drug Delivery - Ongoing Clinical Trials